-The Telegraph Call for expert view on complaints against J&J New Delhi: The Supreme Court on Friday asked the Centre to furnish an expert probe committee’s report on allegations that Johnson & Johnson subsidiary DePuy had supplied faulty hip implants to hundreds of patients in India. It also sought the government’s response to a public interest petition that accuses the Centre and Mumbai police of inaction in the matter. A bench headed by Chief...
More »SEARCH RESULT
Total Matching Records found : 72
Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel
-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...
More »Delhi govt likely to put a cap on hospital profits this week -Durgesh Nandan Jha
-The Times of India NEW DELHI: The Delhi government is likely to come out with a policy to cap profit margins for hospitals this week. A first for any state, the policy will cover sale of medicines, consumables and devices to patients. The state government had appointed a nine-member committee in December last year to suggest the scope and process of capping prices. The move followed public outrage on the death of...
More »The tightrope walk of India's drug-price regulator -Anuj Gupta
-The Economic Times The genesis: The National Pharmaceutical Pricing Authority (NPPA) was set up to implement the 1995 Drug Price Control Order (DPCO) and monitor overcharging of drugs and Medical devices When: August 29, 1997 Total number of chairmen: 11 What the chairman has to deliver: * Implement and enforce the provisions of the DPCO * Render advice to the central government on drug pricing Highlights of the chairmen's tenures * Between 2001 and 2004, five chairmen were...
More »Transfer of NPPA head who capped stent, implant prices sparks protests
-The Times of India The transfer of the chairman of the National Pharmceutical Pricing Authority, Bhupendra Singh, who had capped the price of stents and knee implants and exposed the huge margins being charged by corporate hospitals has evoked howls of protest from public health activists. RSS-affiliate Swadeshi Jagran Manch too has taken exception to the move, tweeting sarcastically about the “reward” given to a bureaucrat for doing a good job. The All...
More »
